OxyContin maker Purdue Pharma loses bid to delay opioid epidemic trial
OxyContin maker Purdue Pharma LP and two other drugmakers on Friday lost a bid to delay a landmark trial set for May in a multibillion-dollar lawsuit by Oklahoma's attorney general accusing them of helping fuel an opioid abuse and overdose epidemic in the state.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Epidemics | Epidemiology | Health | Lawsuits | Legislation | Overdose | Oxycodone | OxyContin | Pharmaceuticals